oXarelto is an anticoagulant which is used primarily to prevent blood clots following surgery. Xarelto can also be prescribed to prevent strokes in patients with atrial fibrillation. Xarelto belongs to a class of anticoagulants known as Factor Xa inhibitors. These drugs work by suppressing the body’s natural production of thrombin, which in turn prevents blood from clotting. Unfortunately, Xarelto has been linked to severe and deadly side effects such as uncontrollable internal bleeding. In 2014, the US Food and Drug Administration required the manufacturer of Xarelto to strengthen the drug’s warning label with regard to the risk of bleeding events. Unlike other anticoagulant drugs, there is no antidote that can be given to a patient to reverse the effects of Xarelto. Xarelto can also cause wound complications following surgical procedures. A study involving 1,048 patients who underwent total hip or knee replacement surgery found that 31 of the patients had wound complications, some of which required patients to go back into surgery. Of those 31 patients, 22 had been prescribed Xarelto after their initial surgery. The study authors found this to be statistically significant. If you or a loved one has suffered an uncontrollable bleeding event while taking Xarelto, please call the experienced drug and device attorneys at Franklin D. Azar and Associates today for a free consultation.